[{"address1": "97 River Road", "address2": "Suite A", "city": "Collinsville", "state": "CT", "zip": "06019", "country": "United States", "phone": "800 280 8192", "website": "https://www.kelyniam.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial and maxilla-facial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. Kelyniam Global, Inc. was incorporated in 2005 and is based in Collinsville, Connecticut.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ross  Bjella", "age": 61, "title": "Chairman & CEO", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Terrance  Kurtenbach", "title": "Chief Financial Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Michael  Hamblett", "title": "Director of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Barrow Esq.", "title": "General Counsel and Director of Quality & Regulatory", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark V. Smith M.D.", "title": "VP of Sales & Business Development and Director", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christopher  Mirucki", "title": "Chief Medical Officer", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 4, "open": 0.145, "dayLow": 0.145, "dayHigh": 0.145, "regularMarketOpen": 0.145, "regularMarketDayLow": 0.145, "regularMarketDayHigh": 0.145, "beta": -1.258, "volume": 5000, "regularMarketVolume": 5000, "averageVolume": 11973, "averageVolume10days": 6600, "averageDailyVolume10Day": 6600, "bid": 0.13, "ask": 0.1489, "marketCap": 4238234, "fiftyTwoWeekLow": 0.04, "fiftyTwoWeekHigh": 0.17, "priceToSalesTrailing12Months": 1.5859535, "fiftyDayAverage": 0.1178, "twoHundredDayAverage": 0.07455, "trailingAnnualDividendYield": "NaN", "currency": "USD", "enterpriseValue": 4678417, "profitMargins": -0.081750005, "sharesOutstanding": 30273100, "impliedSharesOutstanding": 31087400, "bookValue": 0.021, "priceToBook": 6.666667, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "earningsQuarterlyGrowth": 4.831, "netIncomeToCommon": -218471, "trailingEps": -0.01, "lastSplitFactor": "2:1", "lastSplitDate": 1236211200, "enterpriseToRevenue": 1.751, "enterpriseToEbitda": -23.665, "52WeekChange": 1.0, "SandP52WeekChange": 0.32258344, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "KLYG", "underlyingSymbol": "KLYG", "shortName": "Kelyniam Global, Inc.", "longName": "Kelyniam Global, Inc.", "firstTradeDateEpochUtc": 1207315800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7e6f51ce-8e7a-3c6d-80ba-359e9e733db1", "messageBoardId": "finmb_29542438", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.14, "recommendationKey": "none", "totalCash": 9066, "ebitda": -197691, "totalDebt": 631990, "quickRatio": 0.66, "currentRatio": 0.731, "totalRevenue": 2672357, "debtToEquity": 101.974, "revenuePerShare": 0.09, "returnOnAssets": -0.0925, "returnOnEquity": -0.31639, "freeCashflow": 98323, "operatingCashflow": -95773, "earningsGrowth": 4.651, "revenueGrowth": 0.131, "grossMargins": 0.7619, "ebitdaMargins": -0.073979996, "operatingMargins": 0.11255, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-20"}]